Israel Englander’s Twist Bioscience TWST Stock Holding History

Israel Englander’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$885K	Buy	+8,600	New	+$560K	﹤0.01%	4395
2025 Q2	–	Sell	-25,000	Closed	-$982K	–	6337
2025 Q1	$982K	Buy	25,000 +5,000	+25%	+$225K	﹤0.01%	4357
2024 Q4	$929K	Buy	+20,000	New	+$904K	﹤0.01%	4260
2024 Q2	–	Sell	-20,400	Closed	-$700K	–	6555
2024 Q1	$700K	Buy	+20,400	New	+$736K	﹤0.01%	4583
2023 Q3	–	Sell	-120,000	Closed	-$2.46M	–	6583
2023 Q2	$2.46M	Buy	120,000 +85,000	+243%	+$1.27M	﹤0.01%	3298
2023 Q1	$528K	Buy	+35,000	New	+$773K	﹤0.01%	4572
2020 Q3	–	Sell	-48,300	Closed	-$2.19M	–	4830
2020 Q2	$2.19M	Buy	48,300 +34,500	+250%	+$1.24M	﹤0.01%	2463
2020 Q1	$422K	Buy	+13,800	New	+$371K	﹤0.01%	2982

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Israel Englander's TWST Position: Q2 2026 in Review

Israel Englander reduced its Twist Bioscience (TWST) stake by 0.99% in Q2 2026, selling an estimated $225K and leaving 347,148 shares worth $35.7M. The position accounts for 0.01% of the portfolio, ranked #1136.

Israel Englander first reported a position in TWST in Q2 2019 and has held it in 29 quarters since. The position peaked at $77.3M in Q3 2023. 334 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Israel Englander held 347,148 shares of Twist Bioscience worth $35.7M as of Q2 2026.
Israel Englander sold 3,456 Twist Bioscience shares in Q2 2026, an estimated $225K.
Twist Bioscience made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1136 holding.
Israel Englander first reported a position in Twist Bioscience in Q2 2019 and has held it in 29 quarters since.
Israel Englander's Twist Bioscience position peaked at $77.3M in Q3 2023.
334 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.